NRG-GU005
|
NRG
|
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GU006
|
NRG
|
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer (BALANCE*) *Biomarker trial of ApaLutamide and rAdiation for recurreNt prostate CancEr
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GU007
|
NRG
|
Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (with Initial Phase I)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GU008
|
NRG
|
Randomized Phase III Trial Incorporating Abiraterone Acetate with Prednisone and Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer after Radical Prostatectomy
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GU009
|
NRG
|
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GU010
|
NRG
|
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GU011
|
NRG
|
A Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GU012
|
NRG
|
Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GU013
|
NRG
|
The Phase III "High Five Trial" Five Fraction Radiation for High-Risk Prostate Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
NRG-GY001
|
NRG
|
A Phase II Trial of Cabozantinib (XL-184) (NSC #761968) in Women with Recurrent; Clear Cell Carcinoma of the Ovary; Fallopian Tube; or Peritoneum
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|